tiprankstipranks
Advertisement
Advertisement
Dermata Therapeutics Announces Board Resignation and Size Reduction
PremiumCompany AnnouncementsDermata Therapeutics Announces Board Resignation and Size Reduction
3M ago
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity
Premium
Company Announcements
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity
4M ago
Dermata Therapeutics files to sell 1.48M shares of common stock for holders
Premium
The Fly
Dermata Therapeutics files to sell 1.48M shares of common stock for holders
4M ago
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
PremiumRatingsDermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
6M ago
Dermata Therapeutics files $100M mixed securities shelf
Premium
The Fly
Dermata Therapeutics files $100M mixed securities shelf
6M ago
Dermata Therapeutics Ends License Agreement with Villani
Premium
Company Announcements
Dermata Therapeutics Ends License Agreement with Villani
6M ago
Dermata Shifts Focus to Over-the-Counter Dermatology
PremiumCompany AnnouncementsDermata Shifts Focus to Over-the-Counter Dermatology
9M ago
Dermata Therapeutics announces strategic pivot to OTC skin care treatments
Premium
The Fly
Dermata Therapeutics announces strategic pivot to OTC skin care treatments
9M ago
Dermata Therapeutics withdraws IND application for XYNGARI
Premium
The Fly
Dermata Therapeutics withdraws IND application for XYNGARI
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100